Child's Nervous System

, Volume 26, Issue 10, pp 1417–1433

Update on pediatric extracranial vascular anomalies of the head and neck

  • Katherine B. Puttgen
  • Monica Pearl
  • Aylin Tekes
  • Sally E. Mitchell
Special Annual Issue

Abstract

Purpose

Vascular anomalies most frequently present at birth or in early childhood, and the craniofacial region is the most common site of involvement. A long history of misleading nomenclature born of confusion about the presentation and natural history of various vascular anomalies has made appropriate diagnosis difficult. The present article emphasizes the importance of clarity of nomenclature for proper diagnosis, both clinically and radiographically, to guide appropriate therapy. In addition, updates on clinical concepts, imaging, and treatment strategies will be discussed. Pediatric vascular anomalies can be divided into two broad categories: vascular tumors and vascular malformations. This biologic classification is based on differences in natural history, cellular turnover, and histology. An updated classification was introduced in 1996 by the International Society for the Study of Vascular Anomalies (ISSVA) to include infantile hemangioma variants, other benign vascular tumors, and combined lesions. Widespread confusion propagated throughout the literature and in clinical practice stems from the continued improper use of many of the terms used to describe vascular tumors and malformations ignoring their pathophysiology. This leads to errors in diagnosis and the dissemination of misinformation to patients and clinicians. Certain terms should be abandoned for more appropriate terms. The clinical presentation usually identifies what general type of vascular anomaly is present, either vascular tumor or vascular malformation. Imaging provides crucial information about the initial diagnosis and aids in follow-up.

Conclusions

Adoption and use of uniform nomenclature in the ISSVA classification system is the first vital step in correct diagnosis and treatment of often complicated vascular tumors and vascular malformations. A multidisciplinary team approach is necessary to provide optimal care for patients, and the necessity for specialists in all areas to communicate using standardized terminology cannot be overemphasized.

Keywords

Vascular anomaly Hemangioma Venous malformation Arteriovenous malformation Capillary malformation 

References

  1. 1.
    Werner J, Dünne A-A, Folz BJ, Rochels R, Bien S, Ramaswamy S, Lipper BM (2001) Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 258:141–149PubMedCrossRefGoogle Scholar
  2. 2.
    Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69(3):412–422PubMedCrossRefGoogle Scholar
  3. 3.
    Enjolras O, Mulliken JB (1997) Vascular tumors and vascular malformations (new issues). Adv Dermatol 13:375–423PubMedGoogle Scholar
  4. 4.
    Dubois J, Garel L (1999) Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 29:879–893PubMedCrossRefGoogle Scholar
  5. 5.
    Choi D, Alomari AI, Chaudry G, Orbach DB (2009) Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 19:199–218PubMedCrossRefGoogle Scholar
  6. 6.
    Konez O, Burrows PE (2002) Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 10(2):363–388, viiPubMedCrossRefGoogle Scholar
  7. 7.
    Jacobs A, Walton R (1976) The incidence of birthmarks in the neonate. Pediatrics 58:218–222PubMedGoogle Scholar
  8. 8.
    Amir J et al (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3(4):331–332PubMedCrossRefGoogle Scholar
  9. 9.
    Drolet BA, Swanson EA, Frieden IJ (2008) Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 153(5):712–715, 715.e1PubMedCrossRefGoogle Scholar
  10. 10.
    Haggstrom A, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ (2007) Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150(3):291–294PubMedCrossRefGoogle Scholar
  11. 11.
    Chang LC, Haggstrom A, Drolet BA, Baselga E, Chamlin SL, Horii GMC, KA LAW, Mancini AJ, Metry D, Nopper AJ, Frieden IJ (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122(2):360–367PubMedCrossRefGoogle Scholar
  12. 12.
    Finn M, Glowacki J, Mulliken J (1983) Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 18(6):894–900PubMedCrossRefGoogle Scholar
  13. 13.
    Song JK, Niimi Y, Berenstein A (2007) Endovascular treatment of hemangiomas. Neuroimaging Clin N Am 17(2):165–173PubMedCrossRefGoogle Scholar
  14. 14.
    Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P, Adams D, Siegel D, Hall K, Powell J, Frieden I, Drolet B (2009) Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 124(5):1447–1456, Epub 2009 Oct 26PubMedCrossRefGoogle Scholar
  15. 15.
    Haggstrom A, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ (2006) Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117(3):698–703PubMedCrossRefGoogle Scholar
  16. 16.
    Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC (2003) The nonrandom distribution of facial hemangiomas. Arch Dermatol 139(7):869–875PubMedCrossRefGoogle Scholar
  17. 17.
    Heyer G, Millar WS, Ghatan S, Garzon MC (2006) The neurologic aspects of PHACE: case report and review of the literature. Pediatr Neurol 35(6):419–424PubMedCrossRefGoogle Scholar
  18. 18.
    Drolet BA, Dohil M, Golomb MR, Wells R, Murowski L, Tamburro J, Sty J, Friedlander SF (2006) Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 117(3):959–964PubMedCrossRefGoogle Scholar
  19. 19.
    Drosou A, Benjamin L, Linfante I, Mallin K, Trowers A, Wakhloo AK, Thaller SR, Schachner LA (2006) Infantile midline facial hemangioma with agenesis of the corpus callosum and sinus pericranii: another face of the PHACE syndrome. J Am Acad Dermatol 54(2):348–352PubMedCrossRefGoogle Scholar
  20. 20.
    Judd C, Chapman PR, Koch B, Shea CJ (2007) Intracranial infantile hemangiomas associated with PHACE syndrome. AJNR Am J Neuroradiol 28(1):25–29PubMedGoogle Scholar
  21. 21.
    Viswanathan V, Smith ER, Mulliken JB, Fishman SJ, Kozakewich HPW, Burrows PE, Orbach DB (2009) Infantile hemangiomas involving the neuraxis: clinical and imaging findings. AJNR Am J Neuroradiol 30(5):1005–1013PubMedCrossRefGoogle Scholar
  22. 22.
    Pascual-Castroviejo I, Viano J, Moreno F, Palencia R, Martinez Fernandez V, Pascual-Pascual SI, Martinez-Bermejo A, Garcia-Penas JJ, Roche MC (1996) Hemangiomas of the head, neck, and chest with associated vascular and brain anomalies: a complex neurocutaneous syndrome. AJNR Am J Neuroradiol 17(3):461–471PubMedGoogle Scholar
  23. 23.
    Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden I (2006) Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118(3):882–887PubMedCrossRefGoogle Scholar
  24. 24.
    Dubois J, Garel L, Grignon A, David M, Laberge L, Filiatrault D, Powell J (1998) Imaging of hemangiomas and vascular malformations in children. Acad Radiol 5:390–400PubMedCrossRefGoogle Scholar
  25. 25.
    Burrows PE, Laor T, Paltiel H, Robertson R (1998) Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 16(3):455–488PubMedCrossRefGoogle Scholar
  26. 26.
    Burrows PE, Mulliken JB, Fellows KE, Strand RD (1983) Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol 141(3):483–488PubMedGoogle Scholar
  27. 27.
    Wörle H, Maass E, Köhler B, Treuner J (1999) Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication. Eur J Pediatr 158(4):344PubMedCrossRefGoogle Scholar
  28. 28.
    Deb G, Jenkner A, Donfrancesco A (1999) Spastic diplegia and interferon. J Pediatr 134(2):382PubMedGoogle Scholar
  29. 29.
    Barlow C, Priebe CJ, Mulliken JB, Barnes PD, MacDonald D, Folkman J, Ezekowitz RAB (1998) Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 132(3 Pt 1):527–530PubMedGoogle Scholar
  30. 30.
    Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo J-B, Taïeb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358(24):2649–2651PubMedCrossRefGoogle Scholar
  31. 31.
    Leaute-Labreze C, Taieb A (2008) Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Vénéréol 135(12):860–862PubMedCrossRefGoogle Scholar
  32. 32.
    Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian E-N (2009) Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 73:1168–1172PubMedCrossRefGoogle Scholar
  33. 33.
    Buckmiller L (2009) Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 17:458–459PubMedCrossRefGoogle Scholar
  34. 34.
    Lawley L, Siegfried E, Todd J (2009) Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 26(5):61–64CrossRefGoogle Scholar
  35. 35.
    Jephson C, Manunza F, Syed S, Mills NA, Harper J, Hartley BEJ (2009) Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol 73:1821–1823PubMedCrossRefGoogle Scholar
  36. 36.
    Mousa W, Kues K, Haas E, Lauerer P, Pavlakovic H, Schön MP, Zutt M (2010) Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges 8:184–186PubMedCrossRefGoogle Scholar
  37. 37.
    Buckmiller L, Dyamenahalli U, Richter G (2009) Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 119(10):2051–2054PubMedCrossRefGoogle Scholar
  38. 38.
    Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP (2009) Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 23:1465–1466PubMedCrossRefGoogle Scholar
  39. 39.
    Angiero F, Benedicenti S, Benedicenti A, Arcieri K, Bernè E (2009) Head and neck hemangiomas in pediatric patients treated with endolesional 980-nm diode laser. Photomed Laser Surg 27(4):553–559PubMedCrossRefGoogle Scholar
  40. 40.
    Nguyen J, Fay A (2009) Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Ophthalmol 24(3):178–184PubMedCrossRefGoogle Scholar
  41. 41.
    Claude O, Picard A, O’Sullivan N, Baccache S, Momtchilova M, Enjolras O, Vazquez MP, Diner PA (2008) Use of ultrasonic dissection in the early surgical management of periorbital haemangiomas. J Plast Reconstr Aesthet Surg 61(12):1479–1485PubMedCrossRefGoogle Scholar
  42. 42.
    Hamou C, Diner PA, Dalmonte P, Vercellino N, Soupre V, Enjolras O, Vazquez M-P, Picard A (2009) Nasal tip haemangiomas: guidelines for an early surgical approach. J Plast Reconstr Aesthet Surg 63:934–939PubMedCrossRefGoogle Scholar
  43. 43.
    Perkins J, Chen EY, Hoffer FA, Manning SC (2009) Proposal for staging airway hemangiomas. Otolaryngol Head Neck Surg 141(4):516–521PubMedCrossRefGoogle Scholar
  44. 44.
    TM O, Alexander RE, Lando T, Grant NN, Perkins JA, Blitzer A, Waner M (2009) Segmental hemangiomas of the upper airway. Laryngoscope 119(11):2242–2247CrossRefGoogle Scholar
  45. 45.
    Connelly E, Viera M, Price C, Waner M (2009) Segmental hemangioma of infancy complicated by life-threatening arterial bleed. Pediatr Dermatol 26(4):469–472PubMedCrossRefGoogle Scholar
  46. 46.
    Enjolras O, Mulliken J, Boon L, Wassef M, Kozakewich H, Burrows PE (2001) Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 107(7):1647–1654PubMedCrossRefGoogle Scholar
  47. 47.
    Boon L, Enjolras O, Mulliken J (1996) Congenital hemangioma: evidence of accelerated involution. J Pediatr 128(3):329–335PubMedCrossRefGoogle Scholar
  48. 48.
    North P, Waner M, Mizeracki A, Mihm MC (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31(1):11–22PubMedCrossRefGoogle Scholar
  49. 49.
    Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, Burrows PE, Perez-Atayde AR, Kozakewich HPW (2003) Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 6(6):495–510PubMedCrossRefGoogle Scholar
  50. 50.
    Mulliken EO (2004) Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 50(6):875–882PubMedCrossRefGoogle Scholar
  51. 51.
    Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, Taïeb A, Stalder J-F, Escande J-P (1997) Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr 130(4):631–640PubMedCrossRefGoogle Scholar
  52. 52.
    DeFatta R, Verret DJ, Adelson RT, Gomez A, Myers LL (2005) Kaposiform hemangioendothelioma: case report and literature review. Laryngoscope 115(10):1789–1792PubMedCrossRefGoogle Scholar
  53. 53.
    San Miguel F, Spurbeck W, Budding C, Horton J (2008) Kaposiform hemangioendothelioma: a rare cause of spontaneous hemothorax in infancy. Review of the literature. J Pediatr Surg 43(1):e37–e41PubMedCrossRefGoogle Scholar
  54. 54.
    Hauer J, Graubner U, Konstantopoulos N, Schmidt S, Pfluger T, Schmid I (2007) Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer 49(6):852–854PubMedCrossRefGoogle Scholar
  55. 55.
    Chen Y, Wang C-K, Tien Y-C, Hsieh T-J (2009) MRI of multifocal kaposiform haemangioendothelioma without Kasabach-Merritt phenomenon. Br J Radiol 82(975):e51–e54PubMedCrossRefGoogle Scholar
  56. 56.
    Trop I, Dubois J, Guibaud L, Grignon A, Patriquin H, McCuaig C, Garel LA (1999) Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 212(3):841–845PubMedGoogle Scholar
  57. 57.
    Gelbert F, Riche MC, Reizine D, Guichard J-P, Assouline E, Hodes JE, Merland JJ (1991) MR imaging of head and neck vascular malformations. J Magn Reson Imaging 1(5):579–584PubMedCrossRefGoogle Scholar
  58. 58.
    Robertson RL, Robson CD, Barnes PD, Burrows PE (1999) Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am 9(1):115–132PubMedGoogle Scholar
  59. 59.
    Kang G, Song C (2008) Forty-one cervicofacial vascular anomalies and their surgical treatment–retrospection and review. Ann Acad Med Singapore 37(3):165–179PubMedGoogle Scholar
  60. 60.
    Gigantelli J, Leopold DA, Gagnon MR, Arthur JA (2002) Endoscopic transethmoidal decompression of a thrombosed orbital venous malformation. Ear Nose Throat J 81:346-8–351Google Scholar
  61. 61.
    Lacey B, Rootman J, Marotta T (1999) Distensible venous malformations of the orbit: clinical and hemodynamic features and a new technique of management. Ophthalmology 106(6):1197–1209PubMedCrossRefGoogle Scholar
  62. 62.
    Lee C, Chen S (2005) Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck. Br J Plast Surg 58(8):1073–1078PubMedCrossRefGoogle Scholar
  63. 63.
    Tan S, Bialostocki A, Brasch H, Fitzjohn T (2004) Venous malformation of the orbit. J Oral Maxillofac Surg 62(10):1308–1311PubMedCrossRefGoogle Scholar
  64. 64.
    Diolaiuti S, Iizuka T, Schroth G, Remonda L, Laedrach K, El-Koussy M, Frueh BE, Goldblum D (2009) Orbital venous malformation: percutaneous treatment using an electrolytically detachable fibred coil. Acta Ophthalmol 87(2):229–232PubMedCrossRefGoogle Scholar
  65. 65.
    Kishimoto Y, Hirano S, Kato N, Suehiro A, Kanemaru S, Ito J (2008) Endoscopic KTP laser photocoagulation therapy for pharyngolaryngeal venous malformations in adults. Ann Otol Rhinol Laryngol 117(12):881–885PubMedGoogle Scholar
  66. 66.
    Andreisek G, Nanz D, Weishaupt D, Pfammatter T (2009) MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study. J Vasc Interv Radiol 20(7):879–887PubMedCrossRefGoogle Scholar
  67. 67.
    Cabrera J, Cabrera J Jr, García-Olmedo A, Redondo P (2003) Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 139(11):1409–1416PubMedCrossRefGoogle Scholar
  68. 68.
    Berenguer B, Burrows PE, Zurakowski D, Mulliken JB (1999) Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 104(1):1–11, discussion 12-5PubMedCrossRefGoogle Scholar
  69. 69.
    Yun W-S, Kim Y-W, Lee K-B, Kim D-I, Park K-B, Kim K-H, Do Y-S, Lee B-B (2009) Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg 50(3):581–589PubMedCrossRefGoogle Scholar
  70. 70.
    Wong G, Armstrong D, Robertson J (2006) Cardiovascular collapse during ethanol sclerotherapy in a pediatric patient. Pediatr Anesth 16:343–346CrossRefGoogle Scholar
  71. 71.
    Mitchell S, Shah A, Schwengel D (2006) Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted? J Vasc Interv Radiol 17(2 Pt 1):253–262PubMedCrossRefGoogle Scholar
  72. 72.
    Pozo JD, Martnez-Gonzleza C, Verea MM, Fernndez-Torresa R, Fonseca E (2009) Venous malformations with lip involvement: palliative treatment with carbon dioxide laser vaporization in five cases. J Cosmet Laser Ther 11(1):14–18PubMedCrossRefGoogle Scholar
  73. 73.
    Scherer K, Waner M (2007) Nd:YAG lasers (1, 064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci 22(2):119–126PubMedCrossRefGoogle Scholar
  74. 74.
    Chang C, Fisher D, Chen Y (1999) Intralesional photocoagulation of vascular anomalies of the tongue. Br J Plast Surg 52(3):178–181PubMedCrossRefGoogle Scholar
  75. 75.
    Kim A, Ko HK, Won JY, Lee DY (2009) Percutaneous radiofrequency ablation: a novel treatment of facial venous malformation. J Vasc Surg 50(2):424–427PubMedCrossRefGoogle Scholar
  76. 76.
    Ch’ng S, Tan S (2008) Facial port-wine stains—clinical stratification and risks of neuro-ocular involvement. J Plast Reconstr Aesthet Surg 61(8):889–893PubMedCrossRefGoogle Scholar
  77. 77.
    Blei F (2008) Congenital lymphatic malformations. Ann NY Acad Sci 1131:185–194PubMedCrossRefGoogle Scholar
  78. 78.
    López-Gutiérrez J, Lapunzina P (2008) Capillary malformation of the lower lip, lymphatic malformation of the face and neck, asymmetry and partial/generalized overgrowth (CLAPO): report of six cases of a new syndrome/association. Am J Med Genet A 146A(20):2583–2588PubMedCrossRefGoogle Scholar
  79. 79.
    Fordham LA, Chung CJ, Donnelly LF (2000) Imaging of congenital vascular and lymphatic anomalies of the head and neck. Neuroimaging Clin N Am 10(1):117–136, viiiPubMedGoogle Scholar
  80. 80.
    Glade RS, Buckmiller LM (2009) CO2 laser resurfacing of intraoral lymphatic malformations: A 10-year experience. Int J Pediatr Otorhinolaryngol 73(10):1358–1361CrossRefGoogle Scholar
  81. 81.
    Miyazaki H, Kato J, Watanabe H, Harada H, Kakizaki H, Tetsumura A, Sato A, Omura K (2009) Intralesional laser treatment of voluminous vascular lesions in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(2):164–172PubMedCrossRefGoogle Scholar
  82. 82.
    Ryu N-G, Park SK, Jeong H-S (2008) Low power radiofrequency ablation for symptomatic microcystic lymphatic malformation of the tongue. Int J Pediatr Otorhinolaryngol 72(11):1731–1734PubMedCrossRefGoogle Scholar
  83. 83.
    Roy S, Reyes S, Smith LP (2009) Bipolar radiofrequency plasma ablation (Coblation) of lymphatic malformations of the tongue. Int J Pediatr Otorhinolaryngol 73(2):289–293PubMedCrossRefGoogle Scholar
  84. 84.
    W-l C, Zhang B, Wang J-G, Ye H-S, Zhang D-M, Huang Z (2009) Surgical excision of cervicofacial giant macrocystic lymphatic malformations in infants and children. Int J Pediatr Otorhinolaryngol 73(6):833–837CrossRefGoogle Scholar
  85. 85.
    Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Syvlvester KG (2008) Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 43(3):451–460PubMedCrossRefGoogle Scholar
  86. 86.
    Poldervaart MT, Breugem C, Speleman L, Pasmans S (2009) Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofac Surg 20(4):1159–1162PubMedCrossRefGoogle Scholar
  87. 87.
    Shiels WE, Kang DR, Murakami JW, Hogan MJ, Wiet GJ (2009) Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg 141(2):219–224PubMedCrossRefGoogle Scholar
  88. 88.
    Burrows PE, Mitri RK, Alomari A, Padua HM, Lord DJ, Sylvia MB, Fishman SJ, Mulliken JB (2008) Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 6(3–4):209–216PubMedCrossRefGoogle Scholar
  89. 89.
    Bai Y, Jia J, Huang X-X, Alsharif MJ, Zhao J-H, Zhao Y-F (2009) Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 67(2):251–256PubMedCrossRefGoogle Scholar
  90. 90.
    Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJH (2009) Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 119(1):107–115PubMedCrossRefGoogle Scholar
  91. 91.
    Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, Marusasa T, Lane GJ, Yamataka A (2007) Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 42(2):386–389PubMedCrossRefGoogle Scholar
  92. 92.
    Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE (2006) Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 17(10):1639–1648PubMedCrossRefGoogle Scholar
  93. 93.
    Kohout M, Hansen M, Pribaz J, Mulliken JB (1998) Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 102(3):643–654PubMedCrossRefGoogle Scholar
  94. 94.
    Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, Clapuyt P, Hammer F, Dubois J et al (2008) Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 29(7):959–965PubMedCrossRefGoogle Scholar
  95. 95.
    Paltiel HJ, Burrows PE, Kozakewich HPW, Zurakowski D, Mulliken JB (2000) Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 214(3):747–754PubMedGoogle Scholar
  96. 96.
    Legiehn GM, Heran MK (2006) Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin N Am 37(3):435–474, vii-viiiCrossRefGoogle Scholar
  97. 97.
    Cohen JM, Weinreb JC, Redman HC (1986) Arteriovenous malformations of the extremities: MR imaging. Radiology 158(2):475–479PubMedGoogle Scholar
  98. 98.
    Jeong H, Baek C-H, Son Y-I, Kim TW, Lee BB, Byun HS (2006) Treatment for extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol 126(3):295–300PubMedGoogle Scholar
  99. 99.
    Moore C, Murphy K, Gailloud P (2006) Improved distal distribution of n-butyl cyanoacrylate glue by simultaneous injection of dextrose 5% through the guiding catheter: technical note. Neuroradiology 48(5):327–332PubMedCrossRefGoogle Scholar
  100. 100.
    Countee R, Vijayanathan T (1980) Intracranial embolization via external carotid artery: report of a case with angiographic documentation. Stroke 11(5):465–468PubMedGoogle Scholar
  101. 101.
    Wu J, Bisdorff A, Gelbert F, Enjolras O, Burrows PE, Mulliken JB (2005) Auricular arteriovenous malformation: evaluation, management, and outcome. Plast Reconstr Surg 115(4):985–995PubMedCrossRefGoogle Scholar
  102. 102.
    Woo H, Song S-Y, Kim Y-D, Bai CH (2008) Arteriovenous malformation of the external ear: a case report. Auris Nasus Larynx 35(4):556–558PubMedCrossRefGoogle Scholar
  103. 103.
    Kim K (2009) Arteriovenous malformation in the pretragal region: case report. Head Neck, in pressGoogle Scholar
  104. 104.
    Richter G et al (2007) Arteriovenous malformations of the tongue: a spectrum of disease. Laryngoscope 117(2):328–335PubMedCrossRefGoogle Scholar
  105. 105.
    Slaba S, Herbreteau D, Jhaveri HS, Casasco A, Aymard A, Houdart E, Aoun N, Riché MC, Enjolras O, Merland JJ (1998) Therapeutic approach to arteriovenous malformations of the tongue. Eur Radiol 8(2):280–285PubMedCrossRefGoogle Scholar
  106. 106.
    Persky M, Yoo H, Berenstein A (2003) Management of vascular malformations of the mandible and maxilla. Laryngoscope 113(11):1885–1892PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Katherine B. Puttgen
    • 1
  • Monica Pearl
    • 2
  • Aylin Tekes
    • 3
  • Sally E. Mitchell
    • 4
  1. 1.Department of Dermatology, Division of Pediatric DermatologyThe Johns Hopkins HospitalBaltimoreUSA
  2. 2.Department of Radiology, Division of Interventional NeuroradiologyThe Johns Hopkins HospitalBaltimoreUSA
  3. 3.Department of Radiology, Division of Pediatric RadiologyThe Johns Hopkins HospitalBaltimoreUSA
  4. 4.Department of Radiology, Division of Interventional RadiologyThe Johns Hopkins HospitalBaltimoreUSA

Personalised recommendations